However, possible associations between KRAS mutational status and metabolic measurements, which may help in clinical management of patients, as well as in identifying risk factors for developing these cancers, have not been investigated in the literature except that a patient with abnormal metabolic parameters and the KRAS G12C mutation has been reported recently [14]. This evidence concerns the gene KRAS and cancer.